Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

William Janssen to Hydroxymethylglutaryl-CoA Reductase Inhibitors

This is a "connection" page, showing publications William Janssen has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.

 
Connection Strength
 
 
 
0.078
 
  1. Janssen W, Ghofrani HA, Weissmann N, Grimminger F, Schermuly RT. [Update: Preclinical developments for the treatment of pulmonary arterial hypertension]. Dtsch Med Wochenschr. 2009 Aug; 134 Suppl 5:S157-9.
    View in: PubMed
    Score: 0.065
  2. Morimoto K, Janssen WJ, Fessler MB, McPhillips KA, Borges VM, Bowler RP, Xiao YQ, Kench JA, Henson PM, Vandivier RW. Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease. J Immunol. 2006 Jun 15; 176(12):7657-65.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)